Stockscreener 앱 받기
3.20
0.31%
0.01
시간 외 거래:
3.38
0.18
+5.62%
Genelux Corp 주식(GNLX)의 최신 뉴스
Genelux Corporation stock daily chart insightsJuly 2025 Gainers & Consistent Income Trade Ideas - Newser
Applying Wyckoff theory to Genelux Corporation stockJuly 2025 Fed Impact & Technical Buy Zone Confirmations - Newser
Genelux Corporation stock trend forecastDay Trade & AI Forecasted Entry/Exit Points - Newser
Genelux Corporation stock prediction for this weekMarket Movement Recap & Low Risk Investment Opportunities - Newser
Is a relief rally coming for Genelux Corporation holdersRisk Management & Free Technical Confirmation Trade Alerts - Newser
Technical analysis overview for Genelux Corporation stock [2025 Geopolitical Influence]Free Safe Entry Trade Signal Reports - Newser
How Efficient Is Genelux Corporation at Controlling Operating Costs [July 2025 Analyst Calls]Smart Investment Allocation Tips - Newser
How sentiment analysis helps forecast Genelux CorporationMarket Activity Summary & Capital Protection Trade Alerts - Newser
Genelux Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Genelux Corp.’s Innovative Cancer Treatment Approach Earns Buy Rating - TipRanks
What to do if you’re stuck in Genelux CorporationFree Community Entry Consensus Trade Ideas - Newser
Advanced analytics toolkit walkthrough for Genelux CorporationWeekly Gain Forecast with Momentum Indicators - Newser
News impact scoring models applied to Genelux CorporationStock Entry Point Planner with Volume Spike - Newser
How to escape a deep drawdown in Genelux CorporationIntraday Signal Forecast for Fast Traders - Newser
Why Genelux Corporation stock attracts strong analyst attentionFree AI Driven Buy Alert Trade Blueprint - Newser
Promising Outlook for Genelux Corp. with Olvi-Vec Advancements and Strong Financial Position - TipRanks
Genelux Corp.'s Olvi-Vec: A Promising Oncology Treatment with a Buy Rating - AInvest
Genelux Corp expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Promising Potential of Genelux Corp.’s Olvi-Vec in Oncology: A Buy Rating Based on Clinical Data and Strategic Developments - TipRanks
Can trapped investors hope for a rebound in Genelux CorporationWealth Accumulation Outlook for Safe Investors - Newser
Genelux reports Q2 EPS (20c), consensus (22c) - TipRanks
Genelux Q2 Earnings Exceed Expectations with $0.20 GAAP EPS and $28.1M in Cash and Investments - AInvest
Genelux Q2 Earnings: Phase 3 Ovarian Cancer Trial On Track, 71% Success in Lung Cancer | GNLX Stock News - Stock Titan
Developing predictive dashboards with Genelux Corporation dataFree Daily Top Performing Stock Insights - Newser
Does Genelux Corporation show high probability of reboundAI Intraday Market Movement Prediction Tool - Newser
Building trade automation scripts for Genelux CorporationPattern Recognition Based Market Move Prediction - Newser
Genelux Corporation Stock Approaches Key Moving AverageSwing Trade Entry With Volume Triggers Released - beatles.ru
What are the latest earnings results for Genelux CorporationMarket Forecast Signals For Fast Growth - Jammu Links News
How Genelux Corporation stock performs during market volatilityCapital Growth Summary Over Five Years - Newser
How to use a screener to detect Genelux Corporation breakoutsDividend Strategy Summary With 10-Year Outlook - Newser
Genelux Corporation Added to High Probability Setup ListHigh Conviction Intraday Stock Signals Detected - metal.it
Does Genelux Corporation stock perform well during market downturnsAchieve unparalleled market performance - Jammu Links News
Using AI based signals to follow Genelux CorporationEarnings Report Summary with Market Impact - Newser
Is it the right time to buy Genelux Corporation stockGet alerts on the hottest market movers - Jammu Links News
What drives Genelux Corporation stock priceBreakthrough investment results - Autocar Professional
Genelux Corporation Stock Analysis and ForecastTriple returns potential - Autocar Professional
Genelux stock maintains Buy rating at H.C. Wainwright amid sector news - Investing.com India
Genelux stock maintains Buy rating at H.C. Wainwright amid sector news By Investing.com - Investing.com South Africa
1.67%
자본화:
|
볼륨(24시간):